1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. CARDIO DIAGNOSTICS HOLDINGS INC
Cardio Diagnostics Holdings Inc
XNAS: CDIO
Download real time
1.97 0.09 (4.79%)
86.32% Fall from 52W High
348.4K
XNAS Volume
High volume today

XNAS 04 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Cardio Diagnostics Holdings Inc is on 15 May 2026 for the purpose of Cardio Diagnostics Holdings Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Cardio Diagnostics Holdings Inc

The latest disclosure was made by Peter K. Fung in Cardio Diagnostics Holdings Inc where a trade of 3,205 Stock Options (Right to Buy) done was reported to US exchanges on March 31, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Peter K. Fung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2026 3,205 9,513 - - Stock Options (Right to Buy)
Wendy J. Betts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2026 3,205 9,513 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2026 3,205 10,464 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2026 3,205 10,464 - - Stock Options (Right to Buy)
Peter K. Fung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2025 2,306 6,308 - - Stock Options (Right to Buy)
Wendy J. Betts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2025 2,306 6,308 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2025 2,306 7,259 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2025 2,306 7,259 - - Stock Options (Right to Buy)
Peter K. Fung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2025 1,559 4,002 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2025 1,559 4,953 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2025 1,559 4,953 - - Stock Options (Right to Buy)
Wendy J. Betts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2025 1,559 4,002 - - Stock Options (Right to Buy)
Peter K. Fung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 1,736 2,443 - - Stock Options (Right to Buy)
Wendy J. Betts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 1,736 2,443 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 1,736 3,394 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2025 1,736 3,394 - - Stock Options (Right to Buy)
Peter K. Fung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 18,939 21,211 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 18,939 49,744 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 18,939 49,744 - - Stock Options (Right to Buy)
Wendy J. Betts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 18,939 21,211 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 4,544 30,805 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2024 4,544 30,805 - - Stock Options (Right to Buy)
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 18,686 26,261 - - Stock Options (Right to Buy)
Stanley K. Lau Director 30 Sep 2024 18,686 26,261 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 18,686 26,261 - - Stock Options (Right to Buy)
Oded Levy Director 30 Sep 2024 18,686 26,261 - - Stock Options (Right to Buy)
Timur Dogan Chief Technology Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 68,965 197,310 - 0.3 20,000 Common Stock
Meeshanthini V. Dogan Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 68,965 1,655,429 - 0.3 20,000 Common Stock
Meeshanthini V. Dogan Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 68,965 1,655,429 - 0.3 20,000 Common Stock
Timur Dogan Chief Technology Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 68,965 197,310 - 0.3 20,000 Common Stock
Robert Philibert Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 26,615 1,676,407 - 0.3 7,639 Common Stock
Robert Philibert Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.28 per share. 06 Sep 2024 7,460 1,683,867 - 0.3 2,125 Common Stock
Meeshanthini V. Dogan Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 68,965 1,683,867 - 0.3 20,000 Common Stock
Meeshanthini V. Dogan Chief Technology Officer Purchase of securities on an exchange or from another person at price $ 0.29 per share. 06 Sep 2024 68,965 197,310 - 0.3 20,000 Common Stock
Paul F. Burton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2024 7,575 7,575 - - Stock Options (Right to Buy)
Stanley K. Lau Director 30 Jun 2024 7,575 7,575 - - Stock Options (Right to Buy)
James Intrater Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2024 7,575 7,575 - - Stock Options (Right to Buy)
Oded Levy Director 30 Jun 2024 7,575 7,575 - - Stock Options (Right to Buy)
Paul F. Burton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. 31 Mar 2024 8,803 8,803 - 1.4 12,500 Common Stock
Stanley K. Lau Director 31 Mar 2024 8,803 100,325 - 1.4 12,500 Common Stock
James Intrater Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. 31 Mar 2024 8,803 71,596 - 1.4 12,500 Common Stock
Oded Levy Director 31 Mar 2024 8,803 71,596 - 1.4 12,500 Common Stock
Lau Stanley K. Director 31 Jan 2024 917 91,522 - 2.2 1,999 Common Stock
Meeshanthini Dogan V. Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 238,128 435,467 - - Stock Options (Right to Buy)
Meeshanthini Dogan V. Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 476,256 1,433,958 - - Stock Options (Right to Buy)
Robert Philibert Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 142,876 805,465 - - Stock Options (Right to Buy)
Dogan Timur Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 476,256 1,433,958 - - Stock Options (Right to Buy)
Dogan Timur Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 238,128 435,467 - - Stock Options (Right to Buy)
Abdullahi Khullani VP of Revenue and Strategy 23 Jan 2024 238,128 304,128 - - Stock Options (Right to Buy)
Warren Hosseinion Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 35,719 502,195 - - Stock Options (Right to Buy)
Luqman Elisa Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 35,719 264,832 - - Stock Options (Right to Buy)
Sim Brandon Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. 31 Dec 2023 5,020 62,793 - 2.5 12,500 Common Stock
Lau Stanley K. Director 31 Dec 2023 5,020 90,605 - 2.5 12,500 Common Stock
Levy Oded Director 31 Dec 2023 5,020 62,793 - 2.5 12,500 Common Stock
James Intrater Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. 31 Dec 2023 5,020 62,793 - 2.5 12,500 Common Stock
Lau K. Stanley Director 31 Dec 2023 1,606 85,585 - 2.5 3,999 Common Stock
Brandon Sim Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. 30 Jun 2023 21,008 21,008 - 1.2 25,000 Common Stock
Stanley K. Lau Director 30 Jun 2023 21,008 21,008 - 1.2 25,000 Common Stock
Stanley K. Lau Director 30 Jun 2023 8,403 29,411 - 1.2 10,000 Common Stock
James Intrater Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. 30 Jun 2023 21,008 21,208 - 1.2 25,000 Common Stock
Oded Levy Director 30 Jun 2023 21,008 21,008 - 1.2 25,000 Common Stock
Khullani Abdullahi VP of Revenue and Strategy 23 Jun 2023 66,000 66,000 - - Stock Options (Right to Buy)
Timur Dogan Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 157,750 157,750 - - Stock Options (Right to Buy)
Timur Dogan Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 272,250 272,250 - - Stock Options (Right to Buy)
Robert Philibert Director, Chief Medical Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 148,500 148,500 - - Stock Options (Right to Buy)
Meeshanthini Dogan Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 157,570 157,750 - - Stock Options (Right to Buy)
Meeshanthini Dogan Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 272,250 272,250 - - Stock Options (Right to Buy)
Elisa Luqman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 57,750 57,750 - - Stock Options (Right to Buy)
Warren Hosseinion Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 123,750 123,750 - - Stock Options (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters